GlassScriptPhysician profile
Amanda L Harmon
NPI 1093407041
$1,415.07
in general payments reported to CMS, 2019-2025
17 companies · $588 in 2025
The $588 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $302 · 2024: $525 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $211.35 | 2023-2025 | |
| Astellas Pharma US INC | $207.22 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $181.89 | 2023-2025 | |
| Abbvie INC. | $145.98 | 2023-2025 | |
| Exeltis, USA INC. | $139.12 | 2023-2025 | Slynd |
| Coopersurgical, INC. | $135.60 | 2023-2025 | Paragard T 380a, Sos, Paragard T 380a |
| Millicent US INC | $80.10 | 2025 | Femlyv, Intrarosa |
| Exact Sciences Corporation | $61.78 | 2023-2024 | Cologuard Collection Kit |
| Biogen, INC. | $57.10 | 2025 | Zurzuvae |
| Pfizer INC. | $34.01 | 2024-2025 | |
| Kerecis Limited | $28.13 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organon LLC | $26.42 | 2023-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $25.80 | 2024 | Gemtesa |
| Octapharma USA, INC. | $22.42 | 2025 | Fibryga |
| Sanofi Pasteur INC. | $21.35 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.57 | 2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $17.23 | 2024 | Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.